121 related articles for article (PubMed ID: 32552667)
21. CXCL4 promoted the production of CD4
Xu T; Zhao J; Wang X; Meng Y; Zhao Z; Bao R; Deng X; Bian J; Yang T
Autoimmunity; 2020 Aug; 53(5):289-296. PubMed ID: 32538218
[No Abstract] [Full Text] [Related]
22. Carcinoembryonic antigen-related cell adhesion molecule 1 controls IL-2-dependent regulatory T-cell induction in immune-mediated hepatitis in mice.
Horst AK; Wegscheid C; Schaefers C; Schiller B; Neumann K; Lunemann S; Langeneckert AE; Oldhafer KJ; Weiler-Normann C; Lang KS; Singer BB; Altfeld M; Diehl L; Tiegs G
Hepatology; 2018 Jul; 68(1):200-214. PubMed ID: 29377208
[TBL] [Abstract][Full Text] [Related]
23. Effector and regulatory T-cell function is differentially regulated by RelB within antigen-presenting cells during GVHD.
MacDonald KP; Kuns RD; Rowe V; Morris ES; Banovic T; Bofinger H; O'Sullivan B; Markey KA; Don AL; Thomas R; Hill GR
Blood; 2007 Jun; 109(11):5049-57. PubMed ID: 17327399
[TBL] [Abstract][Full Text] [Related]
24. A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells.
Yu A; Zhu L; Altman NH; Malek TR
Immunity; 2009 Feb; 30(2):204-17. PubMed ID: 19185518
[TBL] [Abstract][Full Text] [Related]
25. Lkb1 in dendritic cells restricts CD8
Chen J; Zhou Y; Chen S; Liu M; Guo W; Wang Q; Su X; Zhao C; Han Z; Feng X; Huang H
Exp Cell Res; 2019 Nov; 384(2):111650. PubMed ID: 31563695
[TBL] [Abstract][Full Text] [Related]
26. In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol.
Schmidt A; Éliás S; Joshi RN; Tegnér J
J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060341
[TBL] [Abstract][Full Text] [Related]
27. Vitamin C Fosters the
Oyarce K; Campos-Mora M; Gajardo-Carrasco T; Pino-Lagos K
Front Immunol; 2018; 9():112. PubMed ID: 29479348
[TBL] [Abstract][Full Text] [Related]
28. Gut Inflammation in Mice Triggers Proliferation and Function of Mucosal Foxp3+ Regulatory T Cells but Impairs Their Conversion from CD4+ T Cells.
Boschetti G; Kanjarawi R; Bardel E; Collardeau-Frachon S; Duclaux-Loras R; Moro-Sibilot L; Almeras T; Flourié B; Nancey S; Kaiserlian D
J Crohns Colitis; 2017 Jan; 11(1):105-117. PubMed ID: 27364948
[TBL] [Abstract][Full Text] [Related]
29. FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3.
Wang L; Liu Y; Han R; Beier UH; Bhatti TR; Akimova T; Greene MI; Hiebert SW; Hancock WW
J Clin Invest; 2015 Mar; 125(3):1111-23. PubMed ID: 25642770
[TBL] [Abstract][Full Text] [Related]
30. Foxp3+ regulatory T cells ensure B lymphopoiesis by inhibiting the granulopoietic activity of effector T cells in mouse bone marrow.
Kim S; Park K; Choi J; Jang E; Paik DJ; Seong RH; Youn J
Eur J Immunol; 2015 Jan; 45(1):167-79. PubMed ID: 25348202
[TBL] [Abstract][Full Text] [Related]
31. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells.
Burchill MA; Yang J; Vogtenhuber C; Blazar BR; Farrar MA
J Immunol; 2007 Jan; 178(1):280-90. PubMed ID: 17182565
[TBL] [Abstract][Full Text] [Related]
32. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells.
Chen X; Bäumel M; Männel DN; Howard OM; Oppenheim JJ
J Immunol; 2007 Jul; 179(1):154-61. PubMed ID: 17579033
[TBL] [Abstract][Full Text] [Related]
33. Constitutive nuclear localization of NFAT in Foxp3+ regulatory T cells independent of calcineurin activity.
Li Q; Shakya A; Guo X; Zhang H; Tantin D; Jensen PE; Chen X
J Immunol; 2012 May; 188(9):4268-77. PubMed ID: 22490438
[TBL] [Abstract][Full Text] [Related]
34. Induction of CD4
Khosravi M; Bidmeshkipour A; Cohen JL; Moravej A; Hojjat-Assari S; Naserian S; Karimi MH
Stem Cell Res Ther; 2018 Oct; 9(1):273. PubMed ID: 30359308
[TBL] [Abstract][Full Text] [Related]
35. CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice.
Kolar P; Knieke K; Hegel JK; Quandt D; Burmester GR; Hoff H; Brunner-Weinzierl MC
Arthritis Rheum; 2009 Jan; 60(1):123-32. PubMed ID: 19116935
[TBL] [Abstract][Full Text] [Related]
36. The anti-CXCL4 antibody depletes CD4(+)CD25(+)FOXP3(+) regulatory T cells in CD4+ T cells from chronic osteomyelitis patients by the STAT5 pathway.
Huang K; Ge S
Ann Palliat Med; 2020 Sep; 9(5):2723-2730. PubMed ID: 32954739
[TBL] [Abstract][Full Text] [Related]
37. CARD11 is dispensable for homeostatic responses and suppressive activity of peripherally induced FOXP3
Policheni A; Horikawa K; Milla L; Kofler J; Bouillet P; Belz GT; O'Reilly LA; Goodnow CC; Strasser A; Gray DH
Immunol Cell Biol; 2019 Sep; 97(8):740-752. PubMed ID: 31087793
[TBL] [Abstract][Full Text] [Related]
38. Functional defects in CD4
Guo H; Zheng M; Zhang K; Yang F; Zhang X; Han Q; Chen ZN; Zhu P
Sci Rep; 2016 Nov; 6():37559. PubMed ID: 27901054
[TBL] [Abstract][Full Text] [Related]
39. Helios+ and Helios- cells coexist within the natural FOXP3+ T regulatory cell subset in humans.
Himmel ME; MacDonald KG; Garcia RV; Steiner TS; Levings MK
J Immunol; 2013 Mar; 190(5):2001-8. PubMed ID: 23359504
[TBL] [Abstract][Full Text] [Related]
40. IL-7 abrogates suppressive activity of human CD4+CD25+FOXP3+ regulatory T cells and allows expansion of alloreactive and autoreactive T cells.
Heninger AK; Theil A; Wilhelm C; Petzold C; Huebel N; Kretschmer K; Bonifacio E; Monti P
J Immunol; 2012 Dec; 189(12):5649-58. PubMed ID: 23129754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
